Frazier Lifesciences Acquisition Corporation Unit
FLACU
FLACU was delisted on the 22nd of November, 2022.
26 hedge funds and large institutions have $47M invested in Frazier Lifesciences Acquisition Corporation Unit in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 6 closing their positions.
12% less capital invested
Capital invested by funds: $53.5M → $47M (-$6.58M)
19% less funds holding
Funds holding: 32 → 26 (-6)
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.26M |
| 2 |
GCL
Glazer Capital LLC
New York
|
-$1.55M |
| 3 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$1M |
| 4 |
BCM
Bluefin Capital Management
New York
|
-$682K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$210K |
FLACU Hedge Fund Activity: Q3 2021 in Review
26 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Unit (FLACU) for Q3 2021, worth a combined $47M — down 12% from $53.5M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of FLACU and 0 opened new positions — a net loss of 6 holders — while 6 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $2.95K. The largest seller was Millennium Management, exiting entirely with an estimated $2.26M sold.
- 26 institutional investors held Frazier Lifesciences Acquisition Corporation Unit (FLACU) as of Q3 2021, down from 32 in Q2 2021.
- Funds reported $47M of Frazier Lifesciences Acquisition Corporation Unit stock for Q3 2021, down 12% quarter-over-quarter.
- 0 funds opened new Frazier Lifesciences Acquisition Corporation Unit positions in Q3 2021 and 6 closed out, a net change of -6 holders.
- The largest Frazier Lifesciences Acquisition Corporation Unit buyer in Q3 2021 was UBS Group, an estimated $2.95K added.
- The largest Frazier Lifesciences Acquisition Corporation Unit seller in Q3 2021 was Millennium Management, an estimated $2.26M sold.
Based on aggregated 13F filings for Q3 2021.